2020, Número S1
<< Anterior Siguiente >>
Med Int Mex 2020; 36 (S1)
Dor neuropática. Diagnóstico e tratamento
Zakka T, Jacobsen-Teixeira M
Idioma: Portugués
Referencias bibliográficas: 14
Paginas: 9-12
Archivo PDF: 359.56 Kb.
FRAGMENTO
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630-5.
Doth AF, Hansson PH, Jensen MP, Taylor RS. The burden of neuropathic pain: A systematic review and meta-analysis of health utilities. 2010;149(2):338-44.
Andrade DC, Teixeira MJ, Galhardoni R, et al. Fisiopatologia da dor neuropática. In: Dor: manual para o clínico. Teixeira MJ, Figueiró JB (Orgs). 2ª ed. Rio de Janeiro: Atheneu; 2019. v. 7. p. 131-42.
Correa-ILLanes G. Dolor neuropático, clasification y estrategias de manejo para médicos generales. Rev Med Clin Condes. 2014;25(2):189-99.
Jacob MTRJ, Jacob BJ. Dor Neuropática. In: Tratado de Dor: publicação da Sociedade Brasileira para Estudo da Dor. de Paula Posso I, Grossmann E, da Fonseca PNB, et al (Orgs). 1 ª ed. Rio de Janeiro: Atheneu; 2017. v. 49. p. 639-50.
Woolf CJ, Mannion RJ. Neuropathic pain, aetiology, symptoms, mechanisms and management. Lancet. 1999;353(9168):1959–64.
Schestatsky P. Definição, diagnóstico e tratamento da dor neuropática. Rev HCPA. 2008;28(3):177-87.
Baron R. Peripheral neurophatic pain: From mechanism to symptoms. Clin J Pain. 2000;16(2 Suppl):S12-20.
de Andrade DC, Ferreira KA, Nishimura CM, Yeng LT, Batista AF, de Sá K, et al. Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory. Health Qual Life Outcomes. 2011;9:107.
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-73.
Attal N, Gruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.
Serrano SC, Grossman E. Anticonvulsivantes. In: Tratado de Dor. da Fonseca PRB, Grossmann E, de Oliveira Jr JO, et al. 1ª ed. Rio de Janeiro: Atheneu; 2017. p. 1697-704.
Kukkar A, Bali A, Singh N, Jaggi AD. Implications and mechanism of action of gabapentin in neurophatic pain. Arch Pharm Res. 2013;36(3):1453-64.
Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: A randomized clinical trial. JAMA Neurol. 2019;76(1):28-34.